Trials / Completed
CompletedNCT05602623
Characterizing the Intraocular Scattering at Different Wavelengths
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Johnson & Johnson Vision Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This is a single-site, unmasked, 4-visit, randomized 3x3 cross-over clinical trial to quantify intraocular light scatter in different age groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Adaptive Optics System (AO) | Subjects will have their higher and lower order aberrations corrected with the AO system. |
Timeline
- Start date
- 2023-05-25
- Primary completion
- 2024-06-12
- Completion
- 2024-06-12
- First posted
- 2022-11-02
- Last updated
- 2025-10-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05602623. Inclusion in this directory is not an endorsement.